1. Home
  2. SWKS vs DVA Comparison

SWKS vs DVA Comparison

Compare SWKS & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyworks Solutions Inc.

SWKS

Skyworks Solutions Inc.

HOLD

Current Price

$57.19

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$149.55

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWKS
DVA
Founded
1962
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
10.0B
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
SWKS
DVA
Price
$57.19
$149.55
Analyst Decision
Hold
Hold
Analyst Count
15
4
Target Price
$72.85
$156.75
AVG Volume (30 Days)
2.7M
644.6K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
5.03%
N/A
EPS Growth
N/A
N/A
EPS
0.53
9.84
Revenue
$4,086,900,000.00
$13,643,069,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
$3.06
$3.07
P/E Ratio
$106.53
$15.43
Revenue Growth
N/A
6.46
52 Week Low
$51.93
$101.00
52 Week High
$90.90
$159.42

Technical Indicators

Market Signals
Indicator
SWKS
DVA
Relative Strength Index (RSI) 56.40 49.72
Support Level $56.52 $145.62
Resistance Level $61.80 $152.31
Average True Range (ATR) 1.72 3.56
MACD 0.47 -0.65
Stochastic Oscillator 92.68 38.57

Price Performance

Historical Comparison
SWKS
DVA

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: